Swedish government increases healthcare spending:
This article was originally published in Clinica
Executive Summary
Over the next four years, the Swedish government is planning to invest some SKr13 billion ($1.3 billion) in the health service. The aim is to support the services of the county councils and the cash will be used to promote measures which allow greater patient access to the health service. The government hopes that the extra money will cut hospital waiting times and aims to secure treatment for patients within three months. It will also be employed to extend the primary care sector and improve elderly and psychiatric care.
You may also be interested in...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.